net dbt
growth assumpt earn
reduc ep lower dental outlook
follow result uncertainti market-wid near-
term growth rate organ declin us organ declin
consum global company-specif reduc ep
estim back lower organ growth assumpt
particular lower na dental consum estim growth
growth tough one-year comp intern dental consum growth
estim growth growth somewhat off-set
increas na dental equip estim growth growth
intern dental equip estim growth growth account
reduc ep estim full year
ep estim reiter neutral rate tuesday
quarter see benefit aid margin
increment concern dental consum growth given market
dynam posit see increas inorgan contribut final
quarter internet brand joint ventur given higher margin natur softwar
vs tradit distribution/priv label remain posit contributor
margin rate ebit growth go forward abil scale
value-ad servic platform potenti key differenti
competit margin
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
one world largest distributor
dental medic product also provid
solut broad rang financi servic
primarili fragment custom base
compani headquart melvil new york
oper countri
remain market leader experienc
growth headwind still trade premium
valuat peer group compani
share gainer across key market dental
busi also see acceler contribut
equip side transit
trend still remain difficult predict na
medic see moder growth due multi-
price object base ev/ebitda close
compani histor trade rang account less visibl growth/margin
opportun off-set demographically-posit end market increment
contribut increas technolog revenu
upsid risk po stronger expect dental consumable/equip sale
either new relationship sirona share win faster uptak
one jv cost ration downsid risk uncertainti creat ftc
complaint alleg price conspiraci henri schein/patterson
companies/benco dental suppli wors expect share gain sirona-rel
revenu new competit amazon creat signific growth margin
pressur segment
michael cherni herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
